These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 19448042)
1. Population pharmacokinetic study of cyclosporine in patients with nephrotic syndrome. Xiaoli D; Qiang F J Clin Pharmacol; 2009 Jul; 49(7):782-8. PubMed ID: 19448042 [TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients. Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156 [TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of cyclosporine in clinical renal transplant patients. Wu KH; Cui YM; Guo JF; Zhou Y; Zhai SD; Cui FD; Lu W Drug Metab Dispos; 2005 Sep; 33(9):1268-75. PubMed ID: 15932953 [TBL] [Abstract][Full Text] [Related]
4. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus. Staatz CE; Tett SE Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452 [TBL] [Abstract][Full Text] [Related]
5. Time-dependent pharmacokinetics of cyclosporine (Neoral) in de novo renal transplant patients. Lukas JC; Suárez AM; Valverde MP; Calvo MV; Lanao JM; Calvo R; Suarez E; Gil AD J Clin Pharm Ther; 2005 Dec; 30(6):549-57. PubMed ID: 16336287 [TBL] [Abstract][Full Text] [Related]
6. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation. Staatz CE; Willis C; Taylor PJ; Lynch SV; Tett SE Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506 [TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of ciprofloxacin in pediatric patients. Rajagopalan P; Gastonguay MR J Clin Pharmacol; 2003 Jul; 43(7):698-710. PubMed ID: 12856383 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough. Schrauder A; Saleh S; Sykora KW; Hoy H; Welte K; Boos J; Hempel G; Grigull L Pediatr Transplant; 2009 Jun; 13(4):444-50. PubMed ID: 18482216 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of population pharmacokinetics of cyclosporin A in renal transplantation patients with NONMEM]. Rui JZ; Zhuo HT; Jiang GH; Chen G Yao Xue Xue Bao; 1995; 30(4):241-7. PubMed ID: 7660791 [TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors. Guo F; Letrent SP; Sharma A Cancer Chemother Pharmacol; 2007 Nov; 60(6):799-809. PubMed ID: 17285315 [TBL] [Abstract][Full Text] [Related]
11. Increased cyclosporine bioavailability induced by experimental nephrotic syndrome in rats. Medeiros M; Pérez-Urizar J; Pedraza-Chaverri J; Muñoz-Arizpe R; Castañeda-Hernández G Can J Physiol Pharmacol; 2007 May; 85(5):502-6. PubMed ID: 17632584 [TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of digoxin in Thai pediatric patients. Preechagoon Y; Somsaard P; Petcharattana S J Med Assoc Thai; 2009 Oct; 92(10):1324-35. PubMed ID: 19845241 [TBL] [Abstract][Full Text] [Related]
13. Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile. Takeda A; Horike K; Onoda H; Ohtsuka Y; Yoshida A; Uchida K; Morozumi K Nephrology (Carlton); 2007 Apr; 12(2):197-204. PubMed ID: 17371346 [TBL] [Abstract][Full Text] [Related]
14. [Population pharmacokinetic study of tacrolimus in patients with hematopoietic stem cell transplant]. Xue L; Rui JZ; Zhang Y; Miao LY Yao Xue Xue Bao; 2009 Oct; 44(10):1145-51. PubMed ID: 20055140 [TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of cyclosporine A in Chinese patients with nephrotic syndrome in individualized drug administration . Liu YO; Jia B; Chen CY; Zhou Y; Cui YM; Zhou FD Int J Clin Pharmacol Ther; 2020 Jan; 58(1):1-9. PubMed ID: 31319907 [TBL] [Abstract][Full Text] [Related]
16. Influence of underlying disease on busulfan disposition in pediatric bone marrow transplant recipients: a nonparametric population pharmacokinetic study. Bertholle-Bonnet V; Bleyzac N; Galambrun C; Mialou V; Bertrand Y; Souillet G; Aulagner G Ther Drug Monit; 2007 Apr; 29(2):177-84. PubMed ID: 17417071 [TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetic study of cyclosporine based on NONMEM in Chinese liver transplant recipients. Sun B; Li XY; Gao JW; Rui JZ; Guo YK; Peng ZH; Liu GL Ther Drug Monit; 2010 Dec; 32(6):715-22. PubMed ID: 21068646 [TBL] [Abstract][Full Text] [Related]
18. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children]. Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Tenderenda E Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123 [TBL] [Abstract][Full Text] [Related]
19. How should microemulsified Cyclosporine A (Neoral) therapy in patients with nephrotic syndrome be monitored? Filler G Nephrol Dial Transplant; 2005 Jun; 20(6):1032-4. PubMed ID: 15814537 [No Abstract] [Full Text] [Related]
20. Teicoplanin population pharmacokinetic analysis in hospitalized patients. Soy D; López E; Ribas J Ther Drug Monit; 2006 Dec; 28(6):737-43. PubMed ID: 17164688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]